Loss-of-function variants in ZNF808 have recently been identified as a cause of pancreatic agenesis (PA), clinically defined as neonatal diabetes (NDM) diagnosed in the first 6 months of life and exocrine pancreatic insufficiency.1 Here, ZNF808 is linked to exocrine pancreatic insufficiency.